Risdiplam: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Risdiplam. Educational only — not medical advice.
Labeled uses
EVRYSDI is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.
Source: FDA labeling via NIH DailyMed (set eceb9a99…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.